Please login to the form below

Not currently logged in
Email:
Password:

Charles River

This page shows the latest Charles River news and features for those working in and with pharma, biotech and healthcare.

Mid-sized European biotechs ‘need more support’

Mid-sized European biotechs ‘need more support’

In a new report commissioned by EFPIA and compiled by Charles River Associates (CRA), the authors were asked to explore the extent to which barriers to growth exist, and to what

Latest news

  • Galapagos divests CRO operations to pursue biotech path Galapagos divests CRO operations to pursue biotech path

    Galapagos divests CRO operations to pursue biotech path. Sells Argenta and BioFocus to Charles River Laboratories for up to 134m. ... The transition will be led by the CEO of Galapagos Services David Smith, who will join Charles River as corporate vice

  • Taking contract research’s pulse Taking contract research’s pulse

    James Foster, CEO of early-stage R&D-focused CRO Charles River Laboratories, has a different view, however, saying that the company currently makes around 25 per cent of its sales

  • Charles River ties up with Theorem for non-clinical testing

    Charles River ties up with Theorem for non-clinical testing. CROs form strategic alliance in bioanalysis, immunogenicity and immunology. ... Charles River Laboratories and Theorem Clinical Research have formed a strategic alliance to provide their

  • Charles River Laboratories acquires Chinese research company

    Charles River Laboratories acquires Chinese research company. Pays $27m for Beijing-based Vital River. ... Through our acquisition of Vital River, Charles River intends to set the standards for research models in China, the third-largest pharmaceutical

  • Solid Foundations

    But how do outsiders get a look in? Nathan Waller, a senior marketing manager with global CRO, Charles River Laboratories, believes the only thing stopping marketing from adopting a higher profile ... It is up to companies like Charles River and

More from news
Approximately 3 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    195+. Galapagos/ Charles River. Acquisition of CRO business. Drug discovery services business.

  • Pharma deals during March 2014 Pharma deals during March 2014

    Galapagos decided to sell its BioFocus and Argenta drug discovery service divisions to Charles River during the month so that it could focus on being an R&D company and use

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Charles River

    Charles River. For more than 60 years, Charles River has provided tailored research models and laboratory animal support services, as well as preclinical and clinical support services, to help our global ... Telephone:800.3195.3430. Address:. Charles

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics